Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.8B | 1.8B | 1.9B |
Cost of revenue | 1.5B | 1.7B | 1.8B | 1.7B |
Gross profit | 20M | 105.7M | 49.2M | 127.6M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 44M | 13.8M | 43.3M | 50.5M |
Other operating expenses | — | — | — | — |
Operating income | -24M | 51.8M | 5.9M | 77.1M |
Non operating interest income | ||||
Income | 8M | -5.4M | 4.3M | 14.0M |
Expense | 26M | 19.4M | 28.0M | 30.8M |
Other income expense | — | — | — | — |
Pretax income | -36M | 24.8M | -18.0M | 71.9M |
Tax provision | -5M | 7.3M | -3.5M | 10.8M |
Net income | -31M | 17.5M | -14.4M | 61.1M |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 3.1B | — | 2.9B | 3.1B |
Diluted average shares | 3.1B | — | 2.9B | 3.1B |
EBITDA | 41M | 93.5M | 56.4M | 145.4M |
Net income from continuing op. | -31M | 17.5M | -14.4M | 61.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |